EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Single-Molecule Immunoassay: From Counting Strategies to CRISPR-Enhanced Biosensing

Mingxin Lu, Jie Cheng iD, Jinhong Guo

ACS Sensors · 2026

DOI: 10.1021/acssensors.6c01523 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Sensors, 2026. Verfasst von Mingxin Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Automation and Intelligent Sensing, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai200240, China. Hauptthemen laut MEDLINE: Biosensing Techniques, CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit nennt 78 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, National Key Research and Development Program of China, National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single-molecule immunoassays (SMIs) overcome the sensitivity limitations of conventional bulk measurements by enabling a paradigm shift from analog to digital signal readouts, thereby facilitating highly sensitive quantification of ultra-low-abundance biomarkers for precision diagnostics. This review provides a systematic overview of recent advances in SMI technologies and the conceptual framework underlying their evolution. First, discretization strategies for single-molecule counting are classified into hard discretization, based on physical confinement, and soft discretization, based on spatiotemporal isolation, within heterogeneous and homogeneous assay systems, respectively. The fundamental mechanisms by which these strategies mitigate diffusion limitations and enhance signal-to-noise ratios are discussed. Second, the integration of SMIs with CRISPR-based diagnostic systems (CRISPR-dx) is examined, with particular emphasis on their complementary roles in target recognition and signal amplification. Finally, recent applications of SMIs in the diagnosis of oncological, neurological, infectious, and cardiovascular diseases are summarized, along with a critical discussion of current engineering challenges and future directions toward clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsImmunoassayHumans

Stichwörter der Autor:innen

CRISPR-Cas biosensingbiomarker detectiondigital bioassayliquid biopsymicrofluidic dropletspoint-of-care testingsignal amplificationsingle-molecule immunoassay

Autor:innen und Institutionen

  • School of Automation and Intelligent Sensing, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai200240, China.
  • Research Center of Shaoxing Keqiao Laboratory Medicine, Chongqing Medical University, Shaoxing312030, China.

ORCID-Profile: Jie Cheng

Förderung

  • Natural Science Foundation of Chongqing Municipality
  • National Key Research and Development Program of China
  • National Science and Technology Major Project

Zitieren

APA

Lu, M., Cheng, J., & Guo, J. (2026). Advances in Single-Molecule Immunoassay: From Counting Strategies to CRISPR-Enhanced Biosensing. ACS Sensors. https://doi.org/10.1021/acssensors.6c01523

Vancouver

Lu M, Cheng J, Guo J. Advances in Single-Molecule Immunoassay: From Counting Strategies to CRISPR-Enhanced Biosensing. ACS Sensors. 2026. doi:10.1021/acssensors.6c01523

BibTeX
@article{Lu2026,
  author = {Lu, Mingxin and Cheng, Jie and Guo, Jinhong},
  title = {Advances in Single-Molecule Immunoassay: From Counting Strategies to CRISPR-Enhanced Biosensing},
  journal = {ACS Sensors},
  year = {2026},
  doi = {10.1021/acssensors.6c01523}
}
Kostenlos starten →